Diagnostic strategies to investigate cerebrospinal fluid involvement in haematological malignancies

Domenico Galati, Rosa Di Noto, Luigi Del Vecchio

Research output: Contribution to journalArticlepeer-review


Central nervous system (CNS) involvement is a fatal complication of certain haematological malignancies with an incidence as high as 25% in specific leukaemia/lymphoma subtypes. It is often accompanied by 'occult' cerebrospinal fluid (CSF) involvement at diagnosis, which is frequently missed by conventional cytology examination. Unfortunately, a diagnostic gold standard is yet unavailable since CSF morphology may be negative for malignant cells in up to 45% of patients with suspected meningeal involvement. New technologies such as flow cytometry, molecular genetics and newer biomarkers may improve sensitivity and specificity facilitating the diagnosis of CNS involvement as well as effective prophylaxis and successful treatment.

Original languageEnglish
Pages (from-to)231-237
Number of pages7
JournalLeukemia Research
Issue number3
Publication statusPublished - Mar 2013


  • Cerebrospinal fluid
  • CSF
  • Haematological malignancies
  • Leptomeninges
  • Meningeal involvement
  • Neoplastic meningitis

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology


Dive into the research topics of 'Diagnostic strategies to investigate cerebrospinal fluid involvement in haematological malignancies'. Together they form a unique fingerprint.

Cite this